s&o logo
  • News
  • Trade Ideas
  • Education
  • Community
Sign Up!
Featured, News

Here’s why Oatly stock is trading higher today

July 24, 2024 George Levine No comments yet

Oatly (NASDAQ: OTLY) shares are trading higher after the company reported second-quarter financial results above analyst estimates.

What Happened: On Wednesday morning, Oatley reported second-quarter EPS of -$0.05, beating the -$0.07 estimate and second-quarter sales of $202.19 million, beating the $201.17 million estimate.

Revenue increased 3.2% from the same period last year. The company drove revenue growth in both the retail channel and foodservice channel in the second quarter of 2024 compared to the second quarter of 2023.

The company also updated its guidance metrics.

Given our solid performance through the first half of the fiscal year, and an increased confidence in our second-half outlook, we are updating our full-year guidance to be more favorable than our prior outlook. In the second half of the year, our priorities will be completing our work on the calibration of resources, investing in high-return demand generating investments, and maintaining our north star target to drive the business toward structural, consistent profitable growth.

Jean-Christophe Flatin, Oatly CEO

Full Year 2024 Outlook: Oatly raised its full year 2024 constant currency revenue growth and adjusted EBITDA guidance and lowered its capital expenditures guidance. The company expects:

  • Constant currency revenue growth in the range of 6% to 10%, compared to the prior expectation of 5% to 10%,
  • Adjusted EBITDA loss in the range of $(35) million to $(50) million, compared to the prior expectation of range of $(35) million to $(60) million, and
  • Capital expenditures below $70 million, compared to the prior expectation of below $75 million.

Oatly was trading 11% higher to $1.11 at the time of writing. The stock has a 52-week high of $2.23 and a 52-week low of $0.44.

  • Earnings

Post navigation

Previous
Next

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Categories

  • Education (15)
  • Featured (46)
  • News (85)
  • Trade Ideas (39)

Recent posts

  • FDA Closes Inspection of BioXcel’s TRANQUILITY II Trial Site, Reinforcing Data Integrity
  • Telomir Pharmaceuticals Breakthrough in Silver-Based Medicine
  • flyExclusive to Acquire Jet.AI’s Aviation Business in Strategic Expansion

Tags

BDRX CDT Conduit Conference Call CURR CURRENC Earnings Evergreen GH Research GHRS Grail GRAL HOLO IINN Inspira Technologies Interview IPWR JTAI KULR LCID Litigation LLY Lucid Motors M&A MedTech MicroCloud Movers MSTR My Size MYSZ News NLSP Novo Nordisk NVO Options Partnerships QNTM Quantum BioPharma Stock Market Stocks TAOP TELO Telomir Pharmaceuticals Traws Pharma TRWS

Continue reading

Featured, News, Trade Ideas

NLS Pharmaceutics and Kadimastem Move Closer to Merger Approval

January 31, 2025 Elisa Clay No comments yet

NLS Pharmaceutics (Nasdaq: NLSP) and Kadimastem (TASE: KDST) have reached a key milestone in their planned merger after Kadimastem’s shareholders approved the deal in a special general meeting. The merger aims to create a Nasdaq-listed biotechnology company with a strong portfolio of treatments for neurodegenerative diseases and diabetes. NLS is now preparing to hold its […]

Featured, News, Trade Ideas

Nukkleus Shares Surge 60% Amid Investor Optimism

January 17, 2025 Elisa Clay No comments yet

Nukkleus Inc. (NASDAQ: NUKK) saw its stock skyrocket by 60% during today’s trading session, marking a significant uptick in investor interest and market activity. The surge comes amid heightened speculation about the company’s growth prospects and potential strategic moves. While no major announcements were made by the company, the sharp increase in share price suggests […]

Featured, News, Trade Ideas

Inspira Technologies Ramps Up Production Readiness Amid hMPV Outbreak

January 10, 2025 Elisa Clay No comments yet

Inspira Technologies (Nasdaq: IINN), a leader in life-support technology innovation, has announced preparations for a potential production increase of its INSPIRA ART100 device. This proactive step comes in response to a recent outbreak of human metapneumovirus (hMPV) in China, which has brought renewed attention to the global need for advanced respiratory care solutions. The company […]

s&o logo

Our primary goal is to empower retail investors with helpful news, guides and trading ideas.

Helpful Links
  • News
  • Trade Ideas
  • Education
  • Community
Resources
  • Privacy Policy
  • Terms & Conditions
  • Contact
Get in touch
  • Email us!

© Copyright 2024, stocks&options. All Rights Reserved.